TBPM-PI-HBr
Sponsors
Spero Therapeutics
Conditions
Acute PyelonephritisComplicated Urinary Tract InfectionHealthy Volunteers
Phase 1
Effect of Tebipenem on Normal Human Intestinal Microbiota
CompletedNCT04376554
Start: 2020-02-10End: 2021-04-06Updated: 2021-05-04
Study of the Absorption, Metabolism, and Excretion of [14C]-Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) Following a Single Oral Dose in Healthy Male Subjects
CompletedNCT04625855
Start: 2020-09-30End: 2020-10-16Updated: 2020-11-12
Study to Assess the Intrapulmonary Pharmacokinetics of SPR859 by Comparing the Plasma, Epithelial Lining Fluid (ELF), and Alveolar Macrophages (AM) Concentrations Following the Oral Administration of Five Doses of SPR994 in Healthy, Nonsmoking Volunteers
CompletedNCT04710407
Start: 2020-12-07End: 2021-03-10Updated: 2021-03-16